| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.5B | $0.5B | $0.4B | $0.5B | $0.5B | $0.5B | $0.3B | $0.3B |
| EPS (Basic) | $5.72 | $5.05 | $4.51 | $5.73 | $5.60 | $5.68 | $4.52 | $4.61 |
| EPS (Diluted) | $5.72 | $5.05 | $4.51 | $5.73 | $5.60 | $5.68 | $4.52 | $4.61 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $38.5B | $39.6B | $38.5B | $37.7B | $37.8B | $34.1B | $32.2B | $22.7B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | — | — |
| Total Liabilities | $30.8B | $32.1B | $31.5B | $31.0B | $31.4B | $27.9B | $26.2B | $18.6B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $7.6B | $7.4B | $7.1B | $6.7B | $6.4B | $6.1B | $6.0B | $4.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.5B | $0.5B | $0.6B | $0.5B | $0.7B | $0.6B | $0.4B | $0.3B |
| Investing Cash Flow | $0.8B | $2.0B | $1.1B | $-2.0B | $-2.7B | $-1.3B | $1.3B | $-0.1B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-1.5B | $-0.9B | $-1.7B | $-0.7B | $3.2B | $1.5B | $-1.5B | $-0.2B |